BRIEF published on 05/07/2024 at 20:05, 1 year 11 months ago INSTALLUX S.A. annonce la mise à disposition de l'avis de convocation à l'AG Euronext Growth Paris Droits De Vote Assemblée Générale Informations Financières INSTALLUX S.A.
BRIEF published on 05/07/2024 at 20:05, 1 year 11 months ago INSTALLUX SA announces the availability of the notice of meeting for the AGM Euronext Growth Paris Voting Rights General Assembly INSTALLUX SA Financial Informations
BRIEF published on 05/07/2024 at 19:35, 1 year 11 months ago Assemblée Générale de JCDecaux SE : Approbation des Résolutions et Renouvellements de Mandats Assemblée Générale Gouvernance D'Entreprise Commissaires Aux Comptes Renouvellement De Mandat JCDecaux SE
BRIEF published on 05/07/2024 at 19:35, 1 year 11 months ago General Meeting of JCDecaux SE: Approval of Resolutions and Renewals of Mandates Corporate Governance General Assembly Auditors JCDecaux SE Renewal Of Mandate
BRIEF published on 05/07/2024 at 19:34, 1 year 11 months ago GenSight Biologics Announces Availability of Prospectus for New Shares Listing on Euronext Paris Euronext Paris Capital Increase Gene Therapy Prospectus GenSight Biologics
BRIEF published on 05/07/2024 at 19:34, 1 year 11 months ago GenSight Biologics annonce la mise à disposition d'un prospectus pour la cotation de nouvelles actions sur Euronext Paris Euronext Paris Augmentation De Capital Thérapie Génique Prospectus Produits Biologiques GenSight
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago HiPay Group Announces Strong First Quarter Results for 2024 Revenue Growth Financial Outlook First Quarter 2024 Omnichannel Payments HiPay Group
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago HiPay Group annonce de solides résultats pour le premier trimestre 2024 Hausse Des Revenus Perspectives Financières Premier Trimestre 2024 Paiements Omnicanaux Groupe HiPay
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago Ajustement de la valeur nominale chez Pharnext Biopharmaceutique Réduction De Capital Valeur Nominale Pharnext Maladies Neurodégénératives
BRIEF published on 05/07/2024 at 19:15, 1 year 11 months ago Adjustment of the nominal value at Pharnext Biopharmaceutical Capital Reduction Pharnext Nominal Value Neurodegenerative Diseases
Published on 04/09/2026 at 19:15, 1 hour 7 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 22 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 42 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 22 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 6 hours 52 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 18:45, 1 hour 37 minutes ago EUROPLASMA: Tirage de 200 obligations convertibles en actions nouvelles pour un montant nominal de 1M€
Published on 04/09/2026 at 18:15, 2 hours 6 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 20:00, 22 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2026
Published on 04/09/2026 at 18:35, 1 hour 47 minutes ago Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 30 avril 2026
Published on 04/09/2026 at 18:35, 1 hour 47 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:45, 2 hours 37 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2026
